Middle East and Africa Neurological Biomarker Market Trends and Analysis by 2027

Historic Data: 2017-2018 | Base Year: 2019 | Forecast Period: 2020-2027

Middle East and Africa Neurological Biomarker Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Proteomics Biomarker, Genomics Biomarker, Metabolomics Biomarker, Imaging Biomarker, and Others), Application (Alzheimer’s Disease, Parkinson's Disease, Schizophrenia, Huntington's Disease, Spinal Muscular Atrophy, and Others), and End User (Pharmaceutical & Biotechnology Companies, Clinical Diagnostics, and Research Organizations)

Report Date : Apr 2021
Report Code : TIPRE00020959

Category : Life Sciences
Status : Published

Available Report Formats :
No. of Pages : 121

Page Updated: Apr 2021

Analysis Strategic Insights Market Drivers Regional Insights Report Scope Recent Developments FAQs

The Middle East and Africa neurological biomarker market is expected to reach US$ 529.04 million by 2027 from US$ 232.80 million in 2019; it is estimated to grow at a CAGR of 11.0% from 2020 to 2027.

The growth of the market is attributed to a few key driving factors such as rising prevalence of neurological diseases and growing focus on neurological biomarker research. On the other hand, concerns associated with the use of biomarkers such as the absence of pre-analytical tests are among the major factors that hinder the market growth.

Neurological biomarkers are molecules present in the cerebral spinal fluid (CSF) or blood that support the diagnosis of brain disorders and monitor disease progression. These biomarkers' primary sources are genetic mutations, metabolite levels, brain imaging, and changes in protein expression or post-translational modifications. This helps in the early detection of disease and less invasive diagnostics. It also allows faster drug development and is expected to be the effective treatment for Neurological disorders. Currently, research activities focused on biomarkers in neurodegenerative diseases are significantly increasing due to the surging incidence of Alzheimer’s and Parkinson’s diseases across Middle East and Africa. The World Alzheimer's Report 2017 estimated that 4.4 million people aged 60 years and above were living in South Africa, from which ~ 187,000 had Alzheimer’s dementia. Also, the introduction of digital biomarkers and the growing focus on neurological biomarker research are anticipated to propel the growth of the Middle East and Africa neurological biomarker market in the coming years.

The COVID-19 outbreak pandemic has adversely affected the countries in the Middle East and Africa. Patients suffering from severe health conditions such as neurological diseases have been witnessing delays in chronic disease treatment. However, many companies and research institutes are taking initiatives to accelerate research in the diagnosis, treatment, and prevention of the neurological complications that may be caused by COVID-19. Thus, the Middle East and Africa neurological biomarker market is facing challenges due to the COVID-19 outbreak.

This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Middle East and Africa Neurological Biomarkers MarketSegmentation

By Product

Proteomics Biomaker
Genomics Biomarker
Metabolomics Biomarker
Imaging Biomarker
Others

By Application

Alzheimer's Disease
Parkinson's Disease
Schizophrenia
Huntington's Disease
Spinal Muscular Atrophy
Others

By End User

Pharmaceutical and Biotechnology Companies
Clinical Diagnostics
Research Organizations

By Country

UAE
Saudi Arabia
South Africa
Rest of Middle East and Africa

Company Profiles

Thermo Fisher Scientific Inc.
Abbott
Bio-Rad Laboratories Inc.
QIAGEN
Immunarray Pvt. Ltd.
Quest Diagnostics Incorporated
Perkin Elmer, Inc
MERCK KGaA

Middle East and Africa Neurological Biomarker Report Scope

Report Attribute	Details
Market size in 2019	US$ 232.80 Million
Market Size by 2027	US$ 529.04 Million
Global CAGR (2020 - 2027)	11.0%
Historical Data	2017-2018
Forecast period	2020-2027
Segments Covered	By Product Proteomics Biomarker Genomics Biomarker Metabolomics Biomarker Imaging Biomarker By Application Alzheimer's Disease Parkinson's Disease Schizophrenia Huntington's Disease Spinal Muscular Atrophy By End User Pharmaceutical & Biotechnology Companies Clinical Diagnostics Research Organizations
Regions and Countries Covered	Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Thermo Fisher Scientific Inc. Abbott Bio-Rad Laboratories Inc. QIAGEN Immunarray Pvt. Ltd. Quest Diagnostics Incorporated Perkin Elmer, Inc MERCK KGaA

Research Manager

Mrinal Kerhalkar

Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

What are the Middle East and Africa Neurological Biomarker Market report deliverables?

Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
PEST and SWOT Analysis
Market Size Value / Volume - Global, Regional, Country
Industry and Competitive Landscape
Excel Dataset

Recent Reports

Testimonials

I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.

The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

YUKIHIKO ADACHI CEO, Deep Blue, LLC.

We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.

PIYUSH NAGPAL Sr. Vice President, High Beam Global

I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.

Jean-Herve Jenn Chairman, Future Analytica

This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.

John Suzuki President and Chief Executive Officer, Board Director, BK Technologies

The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.

Ran Kedem Partner, Reali Technologies LTDs

Reason to Buy